API
< Back to all clusters
[TECHNOLOGY] · Thailand · 2 sources

started · updated

Professor Yong Phuvavann discusses patent ethics and genetic innovation

Professor Yong Phuvavann, head of the Center of Excellence in Clinical Virology at Chulalongkorn University, has raised scientific and ethical questions regarding patenting new biological innovations. While acknowledging that patents and copyrights are appropriate for protecting innovation, he emphasized that such protections should not infringe upon the rights of others or disrupt natural processes.

Using a hypothetical scenario involving plant varieties, Professor Yong questioned whether using chemical processes to increase chromosome counts (from 2n to 4n) should be classified as creating Genetically Modified Organisms (GMOs), given that chromosomes control the entirety of an organism's DNA. He also raised concerns about the ecological impact of introducing enhanced organisms that might outcompete and lead to the extinction of weaker, natural species.

Reflecting on his own research into diagnostic kits for influenza and hand-foot-and-mouth disease, he noted that while patents are often required as institutional KPIs, he prioritizes public access within Thailand. He suggested that innovators can also choose to protect their processes through trade secrets rather than public patent disclosures.

Entities

Center of Excellence in Clinical Virology · Chulalongkorn University · Yong Phuvavann